A. I and Antibodies
Researchers have uncovered that artificial intelligence (AI) possesses the ability to construct antibodies formulated in a manner that defies conventional human methodology.
In the realm of protein engineering, humans typically adopt an incremental approach involving iterative adjustments until a functional outcome is achieved.
However, this methodology occasionally results in scientists becoming entrenched in endless optimisation efforts for marginal gains.
The integration of AI into this procedure has facilitated the identification of molecules with non-traditional configurations that would have eluded human discovery.
Why it matters: The rapid accumulation of AI-driven breakthroughs in the healthcare domain is becoming increasingly evident. The impending question is: How soon will the cumulative impact of these advancements reshape the landscape of healthcare for the better?